Word

LIFEFORCE

Status

Dead

Status Code

602

Status Date

Wednesday, December 14, 2011

Serial Number

78807660

Mark Type

4000

Filing Date

Monday, February 6, 2006

Abandoned Date

Monday, November 21, 2011

Trademark Owner History

Lifeforce Immune System Bank PLC

Classifications

1 (Based on Intent to Use)(Based on 44(e)) Biological materials in the nature of tissue, namely blood, stem cells,umbilical cords and placentas for scientific and medical research use

5 (Based on Intent to Use) (Based on 44(e)) Medicinal, pharmaceutical, prophylactic and therapeutic preparations for use in contingent autologous transplantation therapy; medicinal, pharmaceutical, prophylactic and therapeutic biological materials, namely blood and blood components for subsequent implantation, blood, blood components and fractions, cellular material, namely blood components for transplantation; cellular material, namely blood components for autotransplantation; blood, blood fractions and blood components for medical, therapeutic or prophylactic purposes; blood components and fractions for injection purposes; blood components and fractions for autotransplantation; blood components and fractions for transfusion, blood components and fractions for adoptive immunotherapy; blood components and fractions for contingent autologous transplantation; leukocyte preparations for medical use; leukocyte-enriched blood fractions for medical use; isolated leukocytes for medical use; leukocyte preparations for cryopreservation and adoptive immunotherapy medical use; cryopreserved blood for medical use; cryopreserved blood fractions and components for medical use; cryopreserved leukocyte preparations for medical use; cryopreserved leukocyte-enriched blood fractions for medical use; cryopreserved isolated leukocytes for medical use; T-cell preparations for medical or clinical use; B-cell preparations for medical or clinical use; cryopreserved T - cells for medical or clinical use; cryopreserved B-cells for medical or clinical use; blood, blood components and fractions for contingent autologous transplantation therapy; leukocyte preparations, leukocyte-enriched blood fractions and isolated leukocytes for contingent autologous transplantation therapy

9 (Based on Intent to Use) (Based on 44(e)) Data banks featuring information regarding cell donors and recorded on a magnetic data carrier; scientific apparatus and instruments for processing data relating to cell banks; apparatus for recording, transmission or reproduction of data relating to cell banks; magnetic data carriers bearing data relating to cell banks and the maintenance thereof data processors and computers for use with cell banks and parts, components and fittings therefor

10 (Based on Intent to Use) (Based on 44(e)) Blood processing or fractionating apparatus and instruments for medical purposes; medical apparatus and instruments for the isolation of blood cells or blood components; medical apparatus and instruments for the isolation of leukocytes; medical apparatus and instruments for the analysis of blood, blood fractions or blood components; leukapheresis apparatus for medical purposes, leukapheresis tubing sets for medical purposes; blood press packs, namely, containers for the manipulation of blood and blood fractions, blood presses, namely, medical apparatus for use with blood press packs, blood collection apparatus and instruments; medical apparatus for cell cryopreservation; medical apparatus for cryopreservation of blood, blood fractions or blood components; medical apparatus for cryopreservation of leukocytes, B-cells or T-cells; vessels for containing cryopreserved biological material; vessels for containing cryopreserved blood, blood fractions or blood components; vessels for containing cryopreserved leukocytes; vessels for containing cryopreserved B-cells or T-cells; parts and fittings therefor

39 (Based on Use in Commerce) (Based on 44(e)) Storage of biological tissues; storage of blood cells; storage of leukocytes, B-cells or T-cells; cryogenic storage of biological tissue or cells; cryogenic storage of biological tissue intended for subsequent implantation, transfusion, injection, transplantation or autotransplantation, storage of blood fractions, blood components, leukocytes, T-cells or B-cells, cryogenic storage of blood, blood fractions, blood components, leukocytes, T-cells or B-cells; storage of blood fractions, blood components, leukocytes, T-cells or B-cells intended for subsequent implantation, transfusion, injection, transplantation or autotransplantation; cryogenic storage of blood, blood fractions, blood components, leukocytes, T-cells or B-cells intended for subsequent implantation, transfusion, injection, transplantation or autotransplantation

44 (Based on Use in Commerce) (Based on 44(e)) Medical services; medical services, namely, immunotherapy services; blood processing services, namely the collection and preservation of human blood; medical services, namely, implantation, leukapheresis, transfusion, injection, transplantation and autotransplantation services; medical services, namely, cellular implantation, transfusion, injection, transplantation or autotransplantation services; medical services, namely, implantation, transfusion, injection, transplantation or autotransplantation services relating to leukocytes, T-cells or B-cells; blood bank services; cell and biological tissue bank services; leukocyte bank services; T-cell and B-cell bank services; banks of blood components, fractions and preparations; blood cell banks; blood sampling and collection services; medical services, namely, blood fractionation and treatment; analytical services for blood for medical purposes; medical services, namely, autologous leukocyte transplantation; medical services, namely, contingent autologous leukocyte transplantation; medical clinics; immunotherapy clinics; implantation, transfusion, injection, transplantation or autotransplantation clinics; blood bank clinics; blood donation centers; blood collection clinics; clinics for autologous leukocyte transplantation; clinics for contingent autologous leukocyte transplantation; health care; hospital services; nursing services; physical therapy; pharmacy advice; physiotherapy, sports medicine services; consultancy services relating to surgery

LIFE FORCE

Trademark Events

Dec 14, 2011

Abandonment Notice Mailed - Failure To Respond

Dec 14, 2011

Abandonment - Failure To Respond Or Late Response

May 18, 2011

Final Refusal Mailed

May 18, 2011

Final Refusal Written

Apr 27, 2011

Lie Checked Susp - To Atty For Action

Oct 14, 2010

Report Completed Suspension Check Case Still Suspended

Apr 8, 2010

Report Completed Suspension Check Case Still Suspended

Oct 6, 2009

Report Completed Suspension Check Case Still Suspended

Apr 6, 2009

Report Completed Suspension Check Case Still Suspended

Oct 6, 2008

Report Completed Suspension Check Case Still Suspended

Apr 3, 2008

Report Completed Suspension Check Case Still Suspended

Oct 3, 2007

Report Completed Suspension Check Case Still Suspended

Apr 2, 2007

Letter Of Suspension Mailed

Apr 2, 2007

Suspension Letter Written

Mar 12, 2007

Amendment From Applicant Entered

Mar 12, 2007

Correspondence Received In Law Office

Mar 12, 2007

Assigned To Lie

Feb 5, 2007

Paper Received

Aug 2, 2006

Non-Final Action Mailed

Aug 1, 2006

Non-Final Action Written

Jul 27, 2006

Assigned To Examiner

Feb 10, 2006

New Application Entered In Tram